Conditions: Methamphetamine
Keywords: methamphetamine addiction
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 140
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.

Detailed description:

Arms:
arm 1: Subjects will receive topiramate (in tablet form) up to 200 mg/day for 13 weeks. arm 2: After randomization subjects will receive topiramate matched placebo (in tablet form), up to 200 mg/day for 13 weeks.

Interventions: intervention 1: Topiramate intervention 2: Placebo Oral Tablet
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: